You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新股暗盤 | 諾輝健康-B(6606.HK)暗盤段暴漲逾170%
格隆匯 02-17 16:26
格隆匯2月17日丨諾輝健康-B(6606.HK)暗盤段現報73.3港元,較發行價26.66港元漲174.94%。公司是中國結直腸癌篩查市場的先行者,產品常衞清是中國首個且目前唯一一個獲得國家藥品監督管理局批准的癌症早篩產品。公司2018年、2019年收益分別為1881.6萬、5827.5萬元人民幣,每股有形資產淨值3.04-4.49港元。此次上市,全球發售7659.8萬股,其中香港發售3829.9萬股,國際發售3829.9萬股,每手500股,一手中籤率2%,香港公開發售獲4133.19倍認購,淨籌約18.986億港元,當中約40%將分配用於為常衞清(作為醫療服務或獨立產品)的商業化及進一步開發提供資金。南方基金等多家基石投資者已合共認購3606.25萬股發售股份,相當於公司緊隨全球發售完成後已發行股本約8.63%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account